Adagene Inc (ADAG)
2.53
-0.04
(-1.56%)
USD |
NASDAQ |
May 17, 16:00
2.53
0.00 (0.00%)
After-Hours: 20:00
Adagene Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 9.970M |
| September 30, 2020 | 8.654M |
| Date | Value |
|---|---|
| December 31, 2019 | 4.694M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
4.694M
Minimum
Dec 2019
9.970M
Maximum
Dec 2020
7.773M
Average
8.654M
Median
Sep 2020
Research and Development Expense (Quarterly) Benchmarks
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | 2.314M |
| Zai Lab Ltd | 54.64M |
| Gracell Biotechnologies Inc (DELISTED) | 12.44M |
| YS Biopharma Co Ltd | 10.81M |